Data / Form D filings / InnovoTEX Inc.
InnovoTEX Inc.: Form D filings
InnovoTEX Inc., a biotechnology company in Austin, TX, filed 5 Form D notices with the SEC between 2023 and 2026. The latest, on August 18, 2026, reports $2.7 million sold of a $4 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3800 NORTH LAMAR BLVD. SUITE 200, Austin, TX, 78756
- Phone
- (570) 510-6372
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1971887
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Amendment | $4,000,000 | $2,720,484 | $1,279,516 | 21 | Nov 19, 2024 | sec.gov |
| Aug 18, 2026 | New notice | $75,000 | $75,000 | 2 | Mar 9, 2026 | sec.gov | |
| Aug 6, 2026 | New notice | $4,000,000 | $749,951 | $3,250,049 | 14 | Nov 19, 2024 | sec.gov |
| Mar 31, 2023 | Amendment | $829,831 | $829,831 | 8 | Mar 21, 2023 | sec.gov | |
| Mar 31, 2023 | New notice | $829,831 | $829,831 | 8 | Mar 21, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Krystle Karoscik | Executive Officer, Director | |
| Jonathan Arambula | Director | |
| Jonathan Sessler | Director | |
| James Hussey | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- BioGene Therapeutics Inc. $3 million · Aug 7, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InnovoTEX Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.